Clinical Trial Update: QOL Improvement After Cardioversion of Persistent AF (QOL-CAFRCT) [NA]

View source ↗

Summary

This clinical trial update shows recruitment for QOL-CAFRCT, a study assessing quality of life after cardioversion in patients with persistent atrial fibrillati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Atrial Fibrillation | NA | Status: RECRUITING